Global Sustained Release Ocular Drug Delivery Systems Market

Global Sustained Release Ocular Drug Delivery Systems Market Research Report 2021

Global Sustained Release Ocular Drug Delivery Systems Market

Global Sustained Release Ocular Drug Delivery Systems Market Research Report 2021


Insights into the Sustained Release Ocular Drug Delivery Systems Market include supply chain optimization, Sustained Release Ocular Drug Delivery Systems challenges, and growth forecasts segmented by region and service type.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Research Predicts that Sustained Release Ocular Drug Delivery Systems Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.

Global Sustained Release Ocular Drug Delivery Systems Market Overview:

Global Sustained Release Ocular Drug Delivery Systems Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Sustained Release Ocular Drug Delivery Systems involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

Impact of COVID-19 on Sustained Release Ocular Drug Delivery Systems Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Sustained Release Ocular Drug Delivery Systems market in 2020.

Global Sustained Release Ocular Drug Delivery Systems Market Segmentation

By Type, Sustained Release Ocular Drug Delivery Systems market has been segmented into:

Liposome

Microcapsules/Nanocapsules

Microspheres/Nanosptheres

Implants

By Application, Sustained Release Ocular Drug Delivery Systems market has been segmented into:

Cataract

Glaucoma

Corneal Transplantation

Others

Regional Analysis:

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Top Key Players Covered in Sustained Release Ocular Drug Delivery Systems market are:

pSivida

Allergan

Icon Bioscience

Ocular Therapeutix

Neurotech Pharmaceuticals

Santen Pharmaceutical

Aciont Inc.

Envisia Therapeutics

GrayBug

Innocore Pharmaceuticals

OHR Pharmaceuticals

PolyActiva

TheraKine

1. Market Overview of Sustained Release Ocular Drug Delivery Systems

1.1 Sustained Release Ocular Drug Delivery Systems Market Overview

1.1.1 Sustained Release Ocular Drug Delivery Systems Product Scope

1.1.2 Market Status and Outlook

1.2 Sustained Release Ocular Drug Delivery Systems Market Size by Regions: 2015 VS 2021 VS 2026

1.3 Sustained Release Ocular Drug Delivery Systems Historic Market Size by Regions (2015-2020)

1.4 Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Regions (2021-2026)

1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)

1.5.1 North America

1.5.2 East Asia

1.5.3 Europe

1.5.4 South Asia

1.5.5 Southeast Asia

1.5.6 Middle East

1.5.7 Africa

1.5.8 Oceania

1.5.9 South America

1.5.10 Rest of the World

1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.6.2 Covid-19 Impact: Commodity Prices Indices

1.6.3 Covid-19 Impact: Global Major Government Policy

2. Covid-19 Impact Sustained Release Ocular Drug Delivery Systems Sales Market by Type (2015-2026)

2.1 Global Sustained Release Ocular Drug Delivery Systems Historic Market Size by Type (2015-2020)

2.2 Global Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Type (2021-2026)

2.3 Liposome

2.4 Microcapsules/Nanocapsules

2.5 Microspheres/Nanosptheres

2.6 Implants

3. Covid-19 Impact Sustained Release Ocular Drug Delivery Systems Sales Market by Application (2015-2026)

3.1 Global Sustained Release Ocular Drug Delivery Systems Historic Market Size by Application (2015-2020)

3.2 Global Sustained Release Ocular Drug Delivery Systems Forecasted Market Size by Application (2021-2026)

3.3 Cataract

3.4 Glaucoma

3.5 Corneal Transplantation

3.6 Others

4. Covid-19 Impact Market Competition by Manufacturers

4.1 Global Sustained Release Ocular Drug Delivery Systems Production Capacity Market Share by Manufacturers (2015-2020)

4.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Manufacturers (2015-2020)

4.3 Global Sustained Release Ocular Drug Delivery Systems Average Price by Manufacturers (2015-2020)

5. Company Profiles and Key Figures in Sustained Release Ocular Drug Delivery Systems Business

5.1 pSivida

5.1.1 pSivida Company Profile

5.1.2 pSivida Sustained Release Ocular Drug Delivery Systems Product Specification

5.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.2 Allergan

5.2.1 Allergan Company Profile

5.2.2 Allergan Sustained Release Ocular Drug Delivery Systems Product Specification

5.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.3 Icon Bioscience

5.3.1 Icon Bioscience Company Profile

5.3.2 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product Specification

5.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.4 Ocular Therapeutix

5.4.1 Ocular Therapeutix Company Profile

5.4.2 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product Specification

5.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.5 Neurotech Pharmaceuticals

5.5.1 Neurotech Pharmaceuticals Company Profile

5.5.2 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Specification

5.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.6 Santen Pharmaceutical

5.6.1 Santen Pharmaceutical Company Profile

5.6.2 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product Specification

5.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.7 Aciont Inc.

5.7.1 Aciont Inc. Company Profile

5.7.2 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product Specification

5.7.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.8 Envisia Therapeutics

5.8.1 Envisia Therapeutics Company Profile

5.8.2 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product Specification

5.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.9 GrayBug

5.9.1 GrayBug Company Profile

5.9.2 GrayBug Sustained Release Ocular Drug Delivery Systems Product Specification

5.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.10 Innocore Pharmaceuticals

5.10.1 Innocore Pharmaceuticals Company Profile

5.10.2 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Specification

5.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.11 OHR Pharmaceuticals

5.11.1 OHR Pharmaceuticals Company Profile

5.11.2 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Specification

5.11.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.12 PolyActiva

5.12.1 PolyActiva Company Profile

5.12.2 PolyActiva Sustained Release Ocular Drug Delivery Systems Product Specification

5.12.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.13 TheraKine

5.13.1 TheraKine Company Profile

5.13.2 TheraKine Sustained Release Ocular Drug Delivery Systems Product Specification

5.13.3 TheraKine Sustained Release Ocular Drug Delivery Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)

6. North America

6.1 North America Sustained Release Ocular Drug Delivery Systems Market Size (2015-2026)

6.2 North America Sustained Release Ocular Drug Delivery Systems Key Players in North America (2015-2020)

6.3 North America Sustained Release Ocular Drug Delivery Systems Market Size by Type (2015-2020)

6.4 North America Sustained Release Ocular Drug Delivery Systems Market Size by Application (2015-2020)

7. East Asia

7.1 East Asia Sustained Release Ocular Drug Delivery Systems Market Size (2015-2026)

7.2 East Asia Sustained Release Ocular Drug Delivery Systems Key Players in North America (2015-2020)

7.3 East Asia Sustained Release Ocular Drug Delivery Systems Market Size by Type (2015-2020)

7.4 East Asia Sustained Release Ocular Drug Delivery Systems Market Size by Application (2015-2020)

8. Europe

8.1 Europe Sustained Release Ocular Drug Delivery Systems Market Size (2015-2026)

8.2 Europe Sustained Release Ocular Drug Delivery Systems Key Players in North America (2015-2020)

8.3 Europe Sustained Release Ocular Drug Delivery Systems Market Size by Type (2015-2020)

8.4 Europe Sustained Release Ocular Drug Delivery Systems Market Size by Application (2015-2020)

9. South Asia

9.1 South Asia Sustained Release Ocular Drug Delivery Systems Market Size (2015-2026)

9.2 South Asia Sustained Release Ocular Drug Delivery Systems Key Players in North America (2015-2020)

9.3 South Asia Sustained Release Ocular Drug Delivery Systems Market Size by Type (2015-2020)

9.4 South Asia Sustained Release Ocular Drug Delivery Systems Market Size by Application (2015-2020)

10. Southeast Asia

10.1 Southeast Asia Sustained Release Ocular Drug Delivery Systems Market Size (2015-2026)

10.2 Southeast Asia Sustained Release Ocular Drug Delivery Systems Key Players in North America (2015-2020)

10.3 Southeast Asia Sustained Release Ocular Drug Delivery Systems Market Size by Type (2015-2020)

10.4 Southeast Asia Sustained Release Ocular Drug Delivery Systems Market Size by Application (2015-2020)

11. Middle East

11.1 Middle East Sustained Release Ocular Drug Delivery Systems Market Size (2015-2026)

11.2 Middle East Sustained Release Ocular Drug Delivery Systems Key Players in North America (2015-2020)

11.3 Middle East Sustained Release Ocular Drug Delivery Systems Market Size by Type (2015-2020)

11.4 Middle East Sustained Release Ocular Drug Delivery Systems Market Size by Application (2015-2020)

12. Africa

12.1 Africa Sustained Release Ocular Drug Delivery Systems Market Size (2015-2026)

12.2 Africa Sustained Release Ocular Drug Delivery Systems Key Players in North America (2015-2020)

12.3 Africa Sustained Release Ocular Drug Delivery Systems Market Size by Type (2015-2020)

12.4 Africa Sustained Release Ocular Drug Delivery Systems Market Size by Application (2015-2020)

13. Oceania

13.1 Oceania Sustained Release Ocular Drug Delivery Systems Market Size (2015-2026)

13.2 Oceania Sustained Release Ocular Drug Delivery Systems Key Players in North America (2015-2020)

13.3 Oceania Sustained Release Ocular Drug Delivery Systems Market Size by Type (2015-2020)

13.4 Oceania Sustained Release Ocular Drug Delivery Systems Market Size by Application (2015-2020)

14. South America

14.1 South America Sustained Release Ocular Drug Delivery Systems Market Size (2015-2026)

14.2 South America Sustained Release Ocular Drug Delivery Systems Key Players in North America (2015-2020)

14.3 South America Sustained Release Ocular Drug Delivery Systems Market Size by Type (2015-2020)

14.4 South America Sustained Release Ocular Drug Delivery Systems Market Size by Application (2015-2020)

15. Rest of the World

15.1 Rest of the World Sustained Release Ocular Drug Delivery Systems Market Size (2015-2026)

15.2 Rest of the World Sustained Release Ocular Drug Delivery Systems Key Players in North America (2015-2020)

15.3 Rest of the World Sustained Release Ocular Drug Delivery Systems Market Size by Type (2015-2020)

15.4 Rest of the World Sustained Release Ocular Drug Delivery Systems Market Size by Application (2015-2020)

16 Sustained Release Ocular Drug Delivery Systems Market Dynamics

16.1 Covid-19 Impact Market Top Trends

16.2 Covid-19 Impact Market Drivers

16.3 Covid-19 Impact Market Challenges

16.4 Porter’s Five Forces Analysis

18 Regulatory Information

17 Analyst's Viewpoints/Conclusions

18 Appendix

18.1 Research Methodology

18.1.1 Methodology/Research Approach

18.1.2 Data Source

18.2 Disclaimer

Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Sustained Release Ocular Drug Delivery Systems Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Who are the dominant players having a strong presence in the Sustained Release Ocular Drug Delivery Systems Market?
Some of the finest and top-notch companies pioneering the Sustained Release Ocular Drug Delivery Systems Market are pSivida, Allergan, Icon Bioscience, Ocular Therapeutix, Neurotech Pharmaceuticals, Santen Pharmaceutical, Aciont Inc., Envisia Therapeutics, GrayBug, Innocore Pharmaceuticals, OHR Pharmaceuticals, PolyActiva, TheraKine.
How is the competition changing gears in the Sustained Release Ocular Drug Delivery Systems Industry?
Emerging markets will create new demands and put pressure on the industry to act quickly. Simultaneously, market players such as pSivida, Allergan, Icon Bioscience, Ocular Therapeutix, Neurotech Pharmaceuticals, Santen Pharmaceutical, Aciont Inc., Envisia Therapeutics, GrayBug, Innocore Pharmaceuticals, OHR Pharmaceuticals, PolyActiva, TheraKine will face challenges from the industry's increasing pace of consolidation, particularly in North America and Europe.
Where are the Sustained Release Ocular Drug Delivery Systems used?
The Sustained Release Ocular Drug Delivery Systems are employed in Cataract, Glaucoma, Corneal Transplantation, Others.
What is the market value of the Sustained Release Ocular Drug Delivery Systems Industry?
In 2024, the Sustained Release Ocular Drug Delivery Systems Market share exceeded USD xx million. Between 2025 and 2030, it will grow at a CAGR of yy%.
What is Sustained Release Ocular Drug Delivery Systems Market Concentration Rate?
In addition to the Sustained Release Ocular Drug Delivery Systems Market share analysis by competitors, the report also includes chapters on the HHI Index, CR4, and CR8 to characterize the concentration rate and competitive character of the Sustained Release Ocular Drug Delivery Systems Market.
What are the top priorities for the growth of the Sustained Release Ocular Drug Delivery Systems Market?
In this highly competitive and rapidly evolving Sustained Release Ocular Drug Delivery Systems Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.